Navigation Links
Kensey Nash Investor Conference Schedule
Date:8/30/2011

EXTON, Pa., Aug. 30, 2011 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the following investor conferences in September.

Kensey Nash will be participating at the Barrington Research Growth Conference 2011 in Chicago on Wednesday, September 7th, 2011.  The presentation materials will be available on the company's website (www.kenseynash.com) at 8:00 a.m. ET on Wednesday, September 7th, 2011.

Michael Celano, Kensey Nash's Chief Financial Officer, will deliver the Company's presentation, at the CL King's 9th Annual Best Ideas Conference at the Omni Berkshire Place Hotel in New York on Tuesday, September 13th, 2011 at 3:45 p.m. (ET).  To hear the live webcast of the Kensey Nash presentation, go to http://www.videonewswire.com/event.asp?id=81468.  The webcast will be archived for ninety days following the live presentation.  The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 3:45 p.m. (ET) on Tuesday, September 13th, 2011.

Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation, at the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York on Wednesday, September 21st, 2011 beginning at approximately at 9:00 a.m. (ET).  The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 9:00 a.m. (ET) on Wednesday, September 21st, 2011.

Joseph W. Kaufmann will deliver the Company's presentation at the Jefferies 2011 Global Healthcare Conference in London on Tuesday, September 27th, 2011 beginning approximately at 10:00 p.m. (ET).  To hear the live webcast of the Kensey Nash presentation, go to http://www.wsw.com/webcast/jeff62/knsy/.  The webcast will be archived for ninety days following the live presentation.  The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 10:00 p.m. (ET) on Tuesday, September 27th, 2011.

About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology.  The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials.  The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.  For more information, visit www.kenseynash.com.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results
2. Kensey Nash Corporation Announces Its Fourth Quarter and Fiscal Year End 2011 Earnings Release Date and Teleconference
3. Kensey Nash Announces New Unsecured Revolving Credit Facility
4. Kensey Nash to Present at the Jefferies 2011 Global Healthcare Conference
5. Kensey Nash Corporation Announces Its Third Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
6. Kensey Nash to Present at the Canaccord Genuity Musculoskeletal Conference
7. Kensey Nash Corporation Announces Its Second Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
8. Kensey Nash Announces a Manufacturing Agreement with and Minority Investment in Orteq Sports Medicine
9. Kensey Nash and Arthrex Announce European Distribution Agreement for the Cartilage Repair Device
10. Kensey Nash to Present at Two Investor Conferences in November
11. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Md. , Dec. 2, 2016 The ... indication for Jardiance (empagliflozin) to reduce the risk of ... mellitus and cardiovascular disease. "Cardiovascular disease ... type 2 diabetes mellitus," said Jean-Marc Guettier , ... Endocrinology Products in FDA,s Center for Drug Evaluation and ...
(Date:12/2/2016)... the ECG Cables And ECG Leadwires Market owing to the ... On the other hand, the Asia-Pacific ... during the forecast period. The market players namely, ... ( Ireland ), Koninklijke Philips N.V. ( ... China ), held major share of the ECG ...
(Date:12/2/2016)... , December 2, 2016 ... Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, Software), ... (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast ... is valued at USD 60.22 Billion in 2016. ... CAGR of 5.5% during the forecast period (2016-2021) ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... ... For over twenty-four years, Doctors on Liens has published a directory of the ... medical care. When the company started in 1997, the directory was a single page ... the now ten-page directory features a vast array of medical specialists stretching from ...
(Date:12/2/2016)... ... 02, 2016 , ... FlexiSpot, a trusted name in sit-stand ... program for all of the company’s desktop riser products. A simple application form ... , FlexiSpot’s unique desktop risers use an advanced dual gas spring hovering system ...
(Date:12/2/2016)... ... December 02, 2016 , ... U.S. Surgeon General, Dr. Vivek Murthy, graces the ... how he was inspired to practice medicine at an early age by his father, ... than making diagnoses and prescribing medicine,” he states. “It is about building relationships with ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi Hovsepian, a ... in the 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. ... their education, experience, and professional associations. , One the most frequently honored ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, ... through labeling, storing, shipping and disposal. The new version is a faster and ...
Breaking Medicine News(10 mins):